Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 9,849 | 8,498 | 9,353 | 10,086 | 10,889 |
| Cost of Goods | 1,711 | 1,576 | 1,530 | 1,766 | 1,521 |
| Gross Profit | 8,138 | 6,922 | 7,823 | 8,320 | 9,368 |
| Operating Expenses | 9,876 | 9,367 | 14,532 | 10,953 | 9,866 |
| Operating Income | -1,027 | -1,869 | -6,179 | -1,867 | 23 |
| Interest Expense | 126 | 119 | 179 | 110 | 193 |
| Other Income | 62 | 97 | 81 | 920 | 1,039 |
| Pre-tax Income | -1,091 | -1,891 | -6,277 | -1,056 | 869 |
| Income Tax | 11 | 11 | 25 | 7 | 7 |
| Net Income Continuous | -1,103 | -1,903 | -6,302 | -1,063 | 862 |
| Minority Interests | -17 | 44 | -8 | -14 | -10 |
| Net Income | $-1,086 | $-1,946 | $-6,294 | $-1,049 | $872 |
| EPS Basic Total Ops | -0.08 | -0.14 | -0.44 | -0.07 | 0.06 |
| EPS Basic Continuous Ops | -0.08 | -0.13 | -0.44 | -0.07 | 0.06 |
| EPS Diluted Total Ops | -0.08 | -0.14 | -0.44 | -0.07 | 0.06 |
| EPS Diluted Continuous Ops | -0.08 | -0.13 | -0.44 | -0.07 | 0.06 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.06 | -0.12 | N/A | N/A |
| EBITDA(a) | $113 | $-719 | $-1,602 | $-621 | $1,224 |